Schedule 13G ownership disclosure
REGENERON PHARMACEUTICALS COM
Common Stock - par value $.001 per share · CUSIP: 75886F107
Event date: 2025-03-31
- Filing-level shares
- 5,546,434.0
- Percent of class
- 5.1%
- JPMORGAN CHASE & CO.
Shares: 5,546,434.0 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000384
- Form type
- SCHEDULE 13G/A
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Apr 22, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership